1. Home
  2. ARI vs IMCR Comparison

ARI vs IMCR Comparison

Compare ARI & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

N/A

Current Price

$10.92

Market Cap

1.4B

Sector

Real Estate

ML Signal

N/A

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

N/A

Current Price

$30.67

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARI
IMCR
Founded
2009
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
ARI
IMCR
Price
$10.92
$30.67
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$11.00
$66.33
AVG Volume (30 Days)
1.3M
366.2K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
9.31%
N/A
EPS Growth
183.51
30.39
EPS
0.16
0.25
Revenue
$271,589,000.00
$249,428,000.00
Revenue This Year
N/A
$14.57
Revenue Next Year
N/A
$8.21
P/E Ratio
$68.09
$122.22
Revenue Growth
N/A
43.05
52 Week Low
$9.39
$27.47
52 Week High
$11.24
$40.71

Technical Indicators

Market Signals
Indicator
ARI
IMCR
Relative Strength Index (RSI) 51.55 50.13
Support Level $9.59 $28.90
Resistance Level $11.17 $34.35
Average True Range (ATR) 0.14 1.32
MACD -0.03 0.18
Stochastic Oscillator 55.26 61.98

Price Performance

Historical Comparison
ARI
IMCR

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: